The Affiliated Nanjing Drum Tower Hospital Of Nanjing University Medical School
Clinical trials sponsored by The Affiliated Nanjing Drum Tower Hospital Of Nanjing University Medical School, explained in plain language.
-
Virus cocktail fights superbug infections when antibiotics fail
Disease control Not yet recruitingThis early-stage study is testing whether personalized cocktails of viruses called bacteriophages can safely treat urinary tract infections caused by bacteria that don't respond to antibiotics. Six patients with drug-resistant infections will receive the virus therapy directly in…
Phase: NA • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for tough bladder cancers: testing a Two-Drug attack
Disease control Not yet recruitingThis study is testing whether adding a drug called entinostat to standard chemotherapy can help control advanced bladder cancer that has stopped responding to initial treatment. It will involve about 29 patients whose cancer cannot be surgically removed and has spread. The main g…
Phase: PHASE1, PHASE2 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Simpler surgery for rectal tumors? study tests newer, faster method
Disease control Not yet recruitingThis study aims to compare two minimally invasive procedures for removing small rectal neuroendocrine tumors. It will test if a newer, simpler method called mDS-EMR is as effective at completely removing the tumor as the standard method (ESD), while potentially being faster, safe…
Phase: NA • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Race against time: can starting treatment faster save lives from herbicide poisoning?
Disease control Not yet recruitingThis study is testing if starting a blood-filtering treatment called CVVHDF immediately after another treatment (hemoperfusion) can improve survival for people with severe diquat herbicide poisoning. It will involve 24 adults who have high levels of the poison in their blood. The…
Phase: PHASE1 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New brain aneurysm treatment trial seeks better outcomes
Disease control Not yet recruitingThis study aims to find out if a newer procedure using a flow diverter device works better than the standard stent-assisted coiling to treat certain brain aneurysms. Researchers will compare how well each method closes the aneurysm, prevents it from coming back, and improves pati…
Phase: PHASE4 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Race against time: can starting blood cleaning earlier save poisoning victims?
Disease control Not yet recruitingThis study is testing if starting a continuous blood-filtering treatment (CVVHDF) right after an initial poison-removal procedure (hemoperfusion) is better than the current standard, which waits until kidney damage develops. It will involve about 267 adults with severe diquat poi…
Phase: PHASE3 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Scientists test Triple-Threat attack on rare, aggressive skin cancer
Disease control Not yet recruitingThis study is testing a new combination treatment for advanced mucosal melanoma, a rare and aggressive cancer. It combines two drugs (carilizumab and apatinib) with targeted radiation therapy. The main goal is to see if this approach can keep the cancer from growing for at least …
Phase: PHASE2 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Doctors test Metabolism-Guided therapy for tough liver cancers
Disease control Not yet recruitingThis study is testing a personalized treatment approach for advanced liver cancer that cannot be removed by surgery. Doctors will analyze each patient's tumor to classify its metabolism and then assign a tailored combination of immunotherapy and other treatments. The goal is to s…
Phase: PHASE2 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Personalized immune cell therapy offers new hope for women struggling to conceive
Disease control Not yet recruitingThis study is testing whether a new treatment using a woman's own specially prepared immune cells can help improve pregnancy success. It is for women who have experienced unexplained infertility or miscarriage and have a specific type of abnormal immune cell in their uterus. Part…
Phase: PHASE2 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC
-
New portable poison detector could speed up diagnosis
Diagnosis Not yet recruitingThis study is testing a new portable blood test kit designed to measure levels of diquat, a toxic herbicide, in people who may have been poisoned. Researchers will compare the results from this new portable device to the standard, more complex laboratory test to see if it's accur…
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Diagnosis
Last updated Apr 01, 2026 14:41 UTC
-
Fish oil pills tested to fight Chemo's numbing side effect
Symptom relief Not yet recruitingThis study aims to find out if taking fish oil supplements can help prevent or lessen nerve damage (peripheral neuropathy) caused by the chemotherapy drug bortezomib. It will involve 200 adults with multiple myeloma who are starting this specific chemo treatment. Researchers will…
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Symptom relief
Last updated Mar 31, 2026 12:10 UTC